| Effect | None |
| Trial Design | Cohort |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 16 |
| Sex | Male |
| Age Range | 30-44, 45-64 |
| Body Types | Obese |
1g of TTA taken daily for 28 days in an open-labelled study, decreases in LDL and increases in HDL apolipoproteins was seen; a drop in diastolic blood pressure (from 88 to 83) was seen despite systolic remaining static (136 to 133). Weight was not decreased when diet was not controlled.
